Virus News and Research

Latest Virus News and Research

The pros and cons of a COVID-19 vaccine booster

The authors provide an overview of current literature available to assess the need for COVID-19 vaccine booster doses and their potential target population.

2 Nov 2021

Mitigating SARS-CoV-2 infection risks among essential food workers

Researchers employ a stochastic quantitative microbial risk assessment model to assess risk reduction measures for controlling SARS-CoV-2 transmission.

2 Nov 2021

NIH to support a four-year study on long-term effects of COVID-19 in pregnancy

The National Institutes of Health will support a four-year follow-up study on the potential long-term effects of COVID-19 on women infected with SARS-CoV-2 during pregnancy.

2 Nov 2021

Research collaboration identifies antibody that limits the severity of coronavirus infections

A research collaboration between scientists at Duke University and the University of North Carolina at Chapel Hill has identified and tested an antibody that limits the severity of infections from a variety of coronaviruses, including those that cause COVID-19 as well as the original SARS illness.

2 Nov 2021

Zinc supplement may help prevent symptoms of respiratory tract infections, analysis finds

A zinc supplement might help stave off the symptoms of respiratory tract infections, such as coughing, congestion, and sore throat, and cut illness duration, suggests a pooled analysis of the available evidence, published in the open access journal BMJ Open.

2 Nov 2021

The influence of SARS-CoV-2 vaccination time on antibody response in healthcare workers

In this study, the researchers observed a significant effect of time of vaccination on the vaccine-induced SARS-CoV-2 immunity, which was estimated by measuring the anti-Spike antibody levels.

2 Nov 2021

Trends in SARS-CoV-2 seroprevalence in Massachusetts

A new study reported findings from a retrospective, de-identified and systematic survey of SARS-CoV-2 seroprevalence among childbearing women in Massachusetts.

2 Nov 2021

Isolation of potent neutralizing monoclonal antibodies using nanoparticles displaying SARS-CoV-2 S glycoprotein

A new study aimed to identify several potent neutralizing RBD-directed and NTD-directed mAbs that used a nanoparticle displaying the S glycoprotein to capture SARS-CoV-2-specific B cells.

2 Nov 2021

‘Not quite on board’: Parents proving a tough sell on covid vax for teens

Even as the U.S. prepares to roll out a covid-19 vaccine to elementary school-aged kids, its efforts to inoculate teenagers — who have been eligible for the shot since May — continue to meet with a lackluster response.

2 Nov 2021

Identification of common genes in COVID-19 and COPD

Based on protein-protein interactions, the paper shows the presence of ten genes that overlap between the two illnesses, also shared by several other deadly and debilitating diseases.

2 Nov 2021

What do we really know about vaccine effectiveness?

The politicization of covid vaccines — and, well, just about everything else having to do with the pandemic — has led to confusion, if not utter fatigue.

2 Nov 2021

Placental cell-type productively infected with SARS-CoV-2

A new preprint describes the development of a new platform for evaluating the risk of SARS-CoV-2 infection in placental tissue.

2 Nov 2021

SARS-CoV-2 variants neutralized by camel nanobodies

Researchers from the US recently isolated two VHH nanobodies - 7A3 and 8A2 - from dromedary camels (Camelus dromedaries) using phage display. These nanobodies were found to have a high affinity for the spike RBD and broad neutralization abilities against SARS-CoV-2 and its variants.

2 Nov 2021

Scientists identify compound that shows potential in easing the symptoms of coronavirus infections

By studying a disease caused by a close cousin of the virus behind COVID-19, a team of scientists has identified a compound that shows potential in easing the symptoms of coronavirus infections.

1 Nov 2021

Rice introduces new online portal to help researchers screen COVID-19 drug candidates

Rice University researchers have introduced an online portal to help researchers screen COVID-19 drug candidates that might attack specific proteins of the SARS-CoV-2 virus.

1 Nov 2021

Transmission of COVID-19 from pet parent to pet documented for first time in the U.S.

For the first time in the U.S., the transmission of COVID-19 from pet parent to pet is documented genetically as part of a study by the Translational Genomics Research Institute (TGen), an affiliate of City of Hope.

1 Nov 2021

Curious case of SARS-CoV-2 Delta variant in a dog

In a recent study, researchers document the detection and sequencing of an AY.3 virus from a 12-year-old Collie living with a SARS-CoV-2-infected owner.

1 Nov 2021

New Australian study identifies key barriers to COVID-19 testing and vaccination

A new study aimed to bridge the gap in a culturally and linguistically diverse population concerning COVID-19 testing intentions and vaccine willingness.

1 Nov 2021

New genetic epidemiology tool provides detailed information about viruses, coinfections

With mask wearing and social distancing on the decline and the cold and flu season upon us, researchers have developed a viral panel that enables the simultaneous testing for SARS-CoV-2 along with numerous common respiratory viruses, that tells us whether other viruses also are at play in patients hard hit by COVID.

1 Nov 2021

Evidence antibodies targeting HCoV-OC43 are robustly boosted in response to SARS-CoV-2 but not vaccination

The magnitude of cross-reactive antibodies correlated well with responses to the SARS-CoV-2 spike protein and the S2 subdomain.

1 Nov 2021

Virus News and Research

Latest Virus News and Research

The pros and cons of a COVID-19 vaccine booster

Mitigating SARS-CoV-2 infection risks among essential food workers

NIH to support a four-year study on long-term effects of COVID-19 in pregnancy

Research collaboration identifies antibody that limits the severity of coronavirus infections

Zinc supplement may help prevent symptoms of respiratory tract infections, analysis finds

The influence of SARS-CoV-2 vaccination time on antibody response in healthcare workers

Trends in SARS-CoV-2 seroprevalence in Massachusetts

Isolation of potent neutralizing monoclonal antibodies using nanoparticles displaying SARS-CoV-2 S glycoprotein

‘Not quite on board’: Parents proving a tough sell on covid vax for teens

Identification of common genes in COVID-19 and COPD

What do we really know about vaccine effectiveness?

Placental cell-type productively infected with SARS-CoV-2

SARS-CoV-2 variants neutralized by camel nanobodies

Scientists identify compound that shows potential in easing the symptoms of coronavirus infections

Rice introduces new online portal to help researchers screen COVID-19 drug candidates

Transmission of COVID-19 from pet parent to pet documented for first time in the U.S.

Curious case of SARS-CoV-2 Delta variant in a dog

New Australian study identifies key barriers to COVID-19 testing and vaccination

New genetic epidemiology tool provides detailed information about viruses, coinfections

Evidence antibodies targeting HCoV-OC43 are robustly boosted in response to SARS-CoV-2 but not vaccination

A new way of characterising biomolecules eBook

Exploring the role of confocal-based high-content imaging in advancing core facilities

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Virus News and Research

Latest Virus News and Research

A new way of characterising biomolecules eBook

Exploring the role of confocal-based high-content imaging in advancing core facilities

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Newsletters you may be interested in